Literature DB >> 1536526

Urine calcium and serum ionized calcium, total calcium and parathyroid hormone concentrations in the diagnosis of primary hyperparathyroidism and familial benign hypercalcaemia.

I R Gunn1, J R Wallace.   

Abstract

A relationship between serum concentrations of ionized calcium and parathyroid hormone (PTH) in persons without parathyroid overactivity was defined by performing an oral calcium load test. As a result, a serum PTH concentration greater than 2.6 pmol/L in a hypercalcaemic patient was regarded as suggestive of hyperparathyroidism. Fasting serum PTH concentrations in 58 patients with surgically and histologically proven primary hyperparathyroidism (PHPT) were all above 2.7 pmol/L (range 3.2-84.5). Thirteen of 20 patients with familial benign hypercalcaemia (FBH) had fasting serum PTH concentrations greater than 2.6 pmol/L (range 1.6-6.1). There was a significant correlation between serum PTH and age in the FBH patients only. Fasting urine calcium excretion (CaE) ranged from 14 to 222 mumol/L of glomerular filtrate in PHPT and 3-34 mumol/L of glomerular filtrate in FBH. The best biochemical discriminant between patients with PHPT and FBH was a plot of fasting serum PTH against CaE. A plot of post-calcium load PTH against post-load CaE showed no further significant advantage in discriminating between the two conditions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1536526     DOI: 10.1177/000456329202900107

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  6 in total

1.  24-hour urinary calcium in primary hyperparathyroidism.

Authors:  Carrie E Black; Richard L Berg; Andrew C Urquhart
Journal:  Clin Med Res       Date:  2013-12

2.  Novel mutations of the calcium-sensing receptor impede differential diagnosis of primary hyperparathyroidism and familial hypocalciuric hypercalcemia.

Authors:  Jagdeep Singh Bhangu; Sabina Baumgartner-Parzer; Lindsay Hargitai; Peter Mazal; Christian Scheuba; Philipp Riss
Journal:  Gland Surg       Date:  2022-01

3.  Diagnosis of normocalcemic hyperparathyroidism by oral calcium loading test.

Authors:  P Hagag; I Revet-Zak; N Hod; T Horne; M J Rapoport; M Weiss
Journal:  J Endocrinol Invest       Date:  2003-04       Impact factor: 4.256

4.  Self limiting neonatal primary hyperparathyroidism associated with familial hypocalciuric hypercalcaemia.

Authors:  H Wilkinson; J James
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

5.  Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications.

Authors:  J Warner; M Epstein; A Sweet; D Singh; J Burgess; S Stranks; P Hill; D Perry-Keene; D Learoyd; B Robinson; P Birdsey; E Mackenzie; B T Teh; J B Prins; J Cardinal
Journal:  J Med Genet       Date:  2004-03       Impact factor: 6.318

6.  Integrated biosensor platform based on graphene transistor arrays for real-time high-accuracy ion sensing.

Authors:  Mantian Xue; Charles Mackin; Wei-Hung Weng; Jiadi Zhu; Yiyue Luo; Shao-Xiong Lennon Luo; Ang-Yu Lu; Marek Hempel; Elaine McVay; Jing Kong; Tomás Palacios
Journal:  Nat Commun       Date:  2022-08-27       Impact factor: 17.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.